|
|
|
|
|
| Table of contents |
|
Acknowledgements
Abbreviations
Foreword
Executive summary
Introduction and background
Outline of the Consolidated Action Plan
Regional analysis of the strengths, weaknesses, opportunities and threats in relation to M/XDR-TB
Areas of intervention (adapted from the objectives of the Global Plan 2011-2015)
1. Prevent the development of M/XDR-TB cases
2. Scale up access to testing for resistance to first- and second-line anti-TB drugs
and to HIV testing among TB patients
3. Scale up access to effective treatment for all forms of drug-resistant TB
4. Scale up TB infection control
5. Strengthen surveillance, including recording and reporting of drug-resistant TB
and treatment outcome monitoring
6. Expand country capacity to scale up the management of drug-resistant TB,
including advocacy, partnership and policy guidance
7. Address the needs of special populations
References and bibliography
Annex 1. Resolution EUR/RC61/R7 of the sixty-first session of the Regional Committee for Europe
Annex 2. Monitoring framework for follow-up of the Consolidated Action Plan to Prevent and Combat M/XDR-TB
Annex 3. Areas of intervention under the Consolidated Action Plan to Prevent and Combat M/XDR-TB
Annex 4. Costs and benefits of implementation of the Consolidated Action Plan to Prevent and Combat M/XDR-TB
Annex 5. Country profiles
|
|
|
